ProQR Therapeutics N.V. buy Chardan Capital
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€1.87
Performance (%)
170.93%
End price
09.11.24
€3.43
Summary
This prediction ended on 09.11.24 with a price of €3.43. The BUY prediction by Chardan_Capital for ProQR Therapeutics N.V. saw massive gains of 170.93%. Chardan_Capital has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 5.710% | 5.710% | -7.495% |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.59
14.03.25
14.03.25
€3.69
14.03.26
14.03.26
-2.89%
08:46
08:46
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
04.11.25
04.11.25
€3.48
04.11.26
04.11.26
-29.13%
08:46
08:46
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.80
08.08.25
08.08.25
€3.43
08.08.26
08.08.26
-13.90%
08:46
08:46
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.10
12.12.24
12.12.24
€3.81
12.12.25
12.12.25
-37.48%
13.12.25
13.12.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-20.11%
11.05.25
11.05.25